198 related articles for article (PubMed ID: 30249614)
1. Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H
Mocking TAM; Verweij EWE; Vischer HF; Leurs R
Mol Pharmacol; 2018 Dec; 94(6):1371-1381. PubMed ID: 30249614
[TBL] [Abstract][Full Text] [Related]
2. Bioluminescence Resonance Energy Transfer Based G Protein-Activation Assay to Probe Duration of Antagonism at the Histamine H
Mocking TAM; Buzink MCML; Leurs R; Vischer HF
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366084
[TBL] [Abstract][Full Text] [Related]
3. A NanoBRET-Based H
Ma X; Gao M; Vischer HF; Leurs R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897787
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of histamine H
Watanabe M; Kobayashi T; Ito Y; Fukuda H; Yamada S; Arisawa M; Shuto S
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3630-3633. PubMed ID: 30385161
[TBL] [Abstract][Full Text] [Related]
5. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H
Rosier N; Grätz L; Schihada H; Möller J; Işbilir A; Humphrys LJ; Nagl M; Seibel U; Lohse MJ; Pockes S
J Med Chem; 2021 Aug; 64(15):11695-11708. PubMed ID: 34309390
[TBL] [Abstract][Full Text] [Related]
6. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding kinetics at histamine H
Reiner D; Stark H
Eur J Pharmacol; 2019 Apr; 848():112-120. PubMed ID: 30703360
[TBL] [Abstract][Full Text] [Related]
8. UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H
Bartole E; Grätz L; Littmann T; Wifling D; Seibel U; Buschauer A; Bernhardt G
J Med Chem; 2020 May; 63(10):5297-5311. PubMed ID: 32420741
[TBL] [Abstract][Full Text] [Related]
9. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
[TBL] [Abstract][Full Text] [Related]
10. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
Bosma R; Moritani R; Leurs R; Vischer HF
Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
[TBL] [Abstract][Full Text] [Related]
11. Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands - Functional characterization and modeling studies on H
Corrêa MF; Balico-Silva AL; Kiss DJ; Fernandes GAB; Maraschin JC; Parreiras-E-Silva LT; Varela MT; Simões SC; Bouvier M; Keserű GM; Costa-Neto CM; Fernandes JPS
Bioorg Med Chem; 2021 Jan; 30():115924. PubMed ID: 33333448
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
[TBL] [Abstract][Full Text] [Related]
13. Development of a Conformational Histamine H
Schihada H; Ma X; Zabel U; Vischer HF; Schulte G; Leurs R; Pockes S; Lohse MJ
ACS Sens; 2020 Jun; 5(6):1734-1742. PubMed ID: 32397705
[TBL] [Abstract][Full Text] [Related]
14. Visualization of the activation of the histamine H3 receptor (H3R) using novel fluorescence resonance energy transfer biosensors and their potential application to the study of H3R pharmacology.
Liu Y; Zeng H; Pediani JD; Ward RJ; Chen LY; Wu N; Ma L; Tang M; Yang Y; An S; Guo XX; Hao Q; Xu TR
FEBS J; 2018 Jun; 285(12):2319-2336. PubMed ID: 29701013
[TBL] [Abstract][Full Text] [Related]
15. Identification of Histamine H
Frandsen IO; Boesgaard MW; Fidom K; Hauser AS; Isberg V; Bräuner-Osborne H; Wellendorph P; Gloriam DE
Sci Rep; 2017 Jul; 7(1):4829. PubMed ID: 28684785
[TBL] [Abstract][Full Text] [Related]
16. 1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H
Corrêa MF; Varela MT; Balbino AM; Torrecilhas AC; Landgraf RG; Troncone LRP; Fernandes JPDS
Chem Biol Drug Des; 2017 Aug; 90(2):317-322. PubMed ID: 28109127
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
Geyer R; Kaske M; Baumeister P; Buschauer A
Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
[TBL] [Abstract][Full Text] [Related]
18. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
[TBL] [Abstract][Full Text] [Related]
19. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
[TBL] [Abstract][Full Text] [Related]
20. The future antihistamines: histamine H3 and H4 receptor ligands.
Yu F; Bonaventure P; Thurmond RL
Adv Exp Med Biol; 2010; 709():125-40. PubMed ID: 21618893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
